|
RRP1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.322400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.860600E-03 |
| Normal-vs-Stage2 |
2.485800E-01 |
| Normal-vs-Stage3 |
1.844230E-01 |
| Normal-vs-Stage4 |
2.722200E-01 |
| Stage1-vs-Stage2 |
7.717000E-01 |
| Stage1-vs-Stage3 |
1.026350E-02 |
| Stage1-vs-Stage4 |
9.965900E-02 |
| Stage2-vs-Stage3 |
6.907500E-02 |
| Stage2-vs-Stage4 |
1.372050E-01 |
| Stage3-vs-Stage4 |
6.076000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.028550E-01 |
| Normal-vs-AfricanAmerican |
2.364200E-01 |
| Normal-vs-Asian |
4.911200E-01 |
| Caucasian-vs-AfricanAmerican |
9.693000E-01 |
| Caucasian-vs-Asian |
3.476400E-01 |
| AfricanAmerican-vs-Asian |
1.319810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.163900E-02 |
| Normal-vs-Female |
1.696820E-01 |
| Male-vs-Female |
1.619260E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.406000E-01 |
| Normal-vs-Extreme_Weight |
3.061300E-03 |
| Normal-vs-Obese |
5.542400E-01 |
| Normal-vs-Extreme_Obese |
1.295010E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.175800E-01 |
| Normal_Weight-vs-Obese |
2.028600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.345970E-01 |
| Extreme_Weight-vs-Obese |
4.177600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.564800E-01 |
| Obese-vs-Extreme_Obese |
2.517700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.835700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.401200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.171770E-02 |
| Normal-vs-Age(81-100Yrs) |
3.582800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.280000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.899560E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.520800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.880000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.124400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.123400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.652400E-02 |
| Normal-VS-Type2 PRCC |
9.352000E-02 |
| Normal-VS-KIRP CIMP |
1.24699994774602E-09 |
| Normal-VS-Unclassified PRCC |
8.044200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.489400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.34759980952026E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
2.103400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.0866999945498E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
3.224200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.6574200000008E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.704400E-03 |
| Normal-vs-N1 |
1.896140E-03 |
| Normal-vs-N2 |
5.919200E-01 |
| N0-vs-N1 |
7.54790000000449E-05 |
| N0-vs-N2 |
9.385900E-02 |
| N1-vs-N2 |
3.294400E-01 |
|
|
